A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.
Saved in:
| Title: | A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC. |
|---|---|
| Authors: | Camidge DR; University of Colorado Cancer Center, Aurora, Colorado., Barlesi F; Assistance Publique Hôpitaux de Marseille, Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale Centre National de la Recherche Scientifique, Aix Marseille University, Marseille, France.; Gustave Roussy, Villejuif, France., Goldman JW; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California., Morgensztern D; Washington University School of Medicine, St. Louis, Missouri., Heist R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Vokes E; University of Chicago Medicine, Chicago, Illinois., Angevin E; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France., Hong DS; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rybkin II; Henry Ford Health System, Detroit, Michigan., Barve M; Mary Crowley Cancer Research Center, Dallas, Texas., Bauer TM; Sarah Cannon Research Institute, Nashville, Tennessee., Delmonte A; Medical Oncology Division, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Dunbar M; AbbVie Inc., North Chicago, Illinois., Motwani M; AbbVie Inc., North Chicago, Illinois., Parikh A; AbbVie Inc., Redwood City, California., Noon E; AbbVie Inc., North Chicago, Illinois., Wu J; AbbVie Inc., North Chicago, Illinois., Blot V; AbbVie Inc., Redwood City, California., Kelly K; University of California Davis Comprehensive Cancer Center, Sacramento, California. |
| Source: | JTO clinical and research reports [JTO Clin Res Rep] 2021 Dec 04; Vol. 3 (1), pp. 100262. Date of Electronic Publication: 2021 Dec 04 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
